Multiplicity in Clinical Trials SCT 2013

From MultXpert

Revision as of 02:21, 6 July 2013 by Wikiadmin (Talk | contribs)
(diff) ← Older revision | Current revision (diff) | Newer revision → (diff)
Jump to: navigation, search

Selected presentations given at the Society for Clinical Trials (SCT) Annual Meeting in Boston, MA on May 19-22, 2013.

Key multiplicity issues: Multistage gatekeeping procedures

Presented by George Kordzakhia, Division of Biometrics I, Office of Biostatistics, Office of the Translational Sciences, Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration.

Download slides.

Incorporation of gatekeeping procedure into sample size re-estimation design: A case study

Presented by Yevgen Tymofyeyev, Janssen RD (jointly with Alex Dmitrienko and Jeff Maca, Quintiles).

Download slides.

Adjusting for multiplicity in clinical trials: Composite and secondary endpoints

Presented by Haihong Li, Vertex (jointly with Abdul J. Sankoh, Vertex).

Download slides.